vs
Foghorn Therapeutics Inc.（FHTX）与FrontView REIT, Inc.（FVR）财务数据对比。点击上方公司名可切换其他公司
FrontView REIT, Inc.的季度营收约是Foghorn Therapeutics Inc.的2.0倍（$18.2M vs $9.2M），FrontView REIT, Inc.净利率更高（2.2% vs -234.3%，领先236.5%），Foghorn Therapeutics Inc.同比增速更快（223.8% vs 12.0%）
Foghorn Therapeutics是一家临床阶段生物技术企业，专注于开发靶向染色质调控系统的创新疗法，用于治疗多种癌症及其他严重疾病，目前推进多款靶向候选药物管线，通过自主研发与战略合作服务全球患者群体。
FHTX vs FVR — 直观对比
营收规模更大
FVR
是对方的2.0倍
$9.2M
营收增速更快
FHTX
高出211.8%
12.0%
净利率更高
FVR
高出236.5%
-234.3%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $9.2M | $18.2M |
| 净利润 | $-21.7M | $400.0K |
| 毛利率 | — | — |
| 营业利润率 | -258.2% | 24.9% |
| 净利率 | -234.3% | 2.2% |
| 营收同比 | 223.8% | 12.0% |
| 净利润同比 | -11.1% | — |
| 每股收益（稀释后） | $-0.35 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FHTXFVR
| Q1 26 | — | $18.2M | ||
| Q4 25 | $9.2M | $16.5M | ||
| Q3 25 | $8.2M | $16.8M | ||
| Q2 25 | $7.6M | $17.6M | ||
| Q1 25 | $6.0M | $16.2M | ||
| Q4 24 | $2.9M | — | ||
| Q3 24 | $7.8M | $14.5M | ||
| Q2 24 | $6.9M | — |
净利润FHTXFVR
| Q1 26 | — | $400.0K | ||
| Q4 25 | $-21.7M | $-4.1M | ||
| Q3 25 | $-15.8M | $4.0M | ||
| Q2 25 | $-17.9M | $-2.9M | ||
| Q1 25 | $-18.8M | $-833.0K | ||
| Q4 24 | $-19.5M | — | ||
| Q3 24 | $-19.1M | $-2.4M | ||
| Q2 24 | $-23.0M | — |
营业利润率FHTXFVR
| Q1 26 | — | 24.9% | ||
| Q4 25 | -258.2% | — | ||
| Q3 25 | -226.9% | — | ||
| Q2 25 | -279.2% | — | ||
| Q1 25 | -385.0% | — | ||
| Q4 24 | -840.5% | — | ||
| Q3 24 | -305.5% | — | ||
| Q2 24 | -386.6% | — |
净利率FHTXFVR
| Q1 26 | — | 2.2% | ||
| Q4 25 | -234.3% | -24.9% | ||
| Q3 25 | -194.4% | 23.9% | ||
| Q2 25 | -237.3% | -16.5% | ||
| Q1 25 | -316.4% | -5.1% | ||
| Q4 24 | -682.9% | — | ||
| Q3 24 | -244.9% | -16.7% | ||
| Q2 24 | -333.6% | — |
每股收益（稀释后）FHTXFVR
| Q1 26 | — | — | ||
| Q4 25 | $-0.35 | $-0.19 | ||
| Q3 25 | $-0.25 | $0.19 | ||
| Q2 25 | $-0.28 | $-0.16 | ||
| Q1 25 | $-0.30 | $-0.06 | ||
| Q4 24 | $-0.23 | — | ||
| Q3 24 | $-0.31 | — | ||
| Q2 24 | $-0.45 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $80.9M | $9.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-108.5M | $514.2M |
| 总资产 | $198.1M | $869.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FHTXFVR
| Q1 26 | — | $9.3M | ||
| Q4 25 | $80.9M | $13.5M | ||
| Q3 25 | $89.3M | $19.6M | ||
| Q2 25 | $72.6M | $8.4M | ||
| Q1 25 | $61.0M | $3.3M | ||
| Q4 24 | $55.5M | — | ||
| Q3 24 | $57.7M | — | ||
| Q2 24 | $138.9M | — |
总债务FHTXFVR
| Q1 26 | — | — | ||
| Q4 25 | — | $314.3M | ||
| Q3 25 | — | $307.1M | ||
| Q2 25 | — | $316.9M | ||
| Q1 25 | — | $310.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益FHTXFVR
| Q1 26 | — | $514.2M | ||
| Q4 25 | $-108.5M | $391.2M | ||
| Q3 25 | $-89.7M | $385.2M | ||
| Q2 25 | $-76.7M | $369.9M | ||
| Q1 25 | $-61.7M | $324.7M | ||
| Q4 24 | $-45.5M | — | ||
| Q3 24 | $-28.3M | $1.0K | ||
| Q2 24 | $-14.3M | — |
总资产FHTXFVR
| Q1 26 | — | $869.8M | ||
| Q4 25 | $198.1M | $854.4M | ||
| Q3 25 | $205.0M | $846.8M | ||
| Q2 25 | $226.2M | $856.5M | ||
| Q1 25 | $258.7M | $860.8M | ||
| Q4 24 | $284.0M | — | ||
| Q3 24 | $308.4M | $1.0K | ||
| Q2 24 | $328.6M | — |
负债/权益比FHTXFVR
| Q1 26 | — | — | ||
| Q4 25 | — | 0.80× | ||
| Q3 25 | — | 0.80× | ||
| Q2 25 | — | 0.86× | ||
| Q1 25 | — | 0.96× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.3M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流FHTXFVR
| Q1 26 | — | — | ||
| Q4 25 | $-22.3M | $42.1M | ||
| Q3 25 | $-18.9M | $8.3M | ||
| Q2 25 | $-21.0M | $9.3M | ||
| Q1 25 | $-24.0M | $8.1M | ||
| Q4 24 | $-24.5M | — | ||
| Q3 24 | $-21.0M | — | ||
| Q2 24 | $-25.5M | — |
自由现金流FHTXFVR
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $-21.0M | — | ||
| Q1 25 | $-24.0M | — | ||
| Q4 24 | $-25.0M | — | ||
| Q3 24 | $-21.3M | — | ||
| Q2 24 | $-25.6M | — |
自由现金流率FHTXFVR
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -278.2% | — | ||
| Q1 25 | -403.2% | — | ||
| Q4 24 | -875.3% | — | ||
| Q3 24 | -273.0% | — | ||
| Q2 24 | -371.0% | — |
资本支出强度FHTXFVR
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 16.8% | — | ||
| Q3 24 | 4.0% | — | ||
| Q2 24 | 0.2% | — |
现金转化率FHTXFVR
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 2.06× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
